cefuroxime axetil (Ceftin)

01/01/2000 - "To assess the safety and efficacy of cefuroxime axetil in the treatment of infections during pregnancy. "
07/01/1987 - "Since the study failed to demonstrate a significant advantage of higher dosage, cefuroxime axetil should be prescribed in a regimen of 250 mg twice a day for patients with skin infections."
01/01/1987 - "A study was carried out in general practice to assess the clinical effectiveness and tolerability of the oral cephalosporin, cefuroxime axetil, in the treatment of 369 patients presenting with acute infections of the upper respiratory tract. "
01/01/1987 - "The efficacy and safety of cefuroxime axetil was studied in a randomized general practice trial in urological infections where cefuroxime axetil 250 mg b.d. "
01/01/2010 - "Cefuroxime axetil is second-generation cephalosporin used to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. "

09/01/1990 - "Cefuroxime axetil is a safe and effective oral antimicrobial for the treatment of pneumonia in adults."
09/01/2000 - "Oral cefuroxime axetil was appropriate for patients with milder pneumonia managed either in hospital or at home."
09/01/2000 - "The oral form, cefuroxime axetil, has been used extensively in the treatment of children aged over 3 months but its use in paediatric pneumonia has not been reviewed. "
03/01/1996 - "One hundred-and-seventeen (117) patients with radiologically confirmed community-acquired pneumonia of presumed bacterial origin were enrolled in a prospective multicenter trial of cefuroxime axetil therapy (500 mg twice daily). "
09/01/1990 - "It is concluded that cefuroxime axetil is safe and effective in the treatment of community-acquired pneumonia or acute bronchitis."

09/01/1996 - "A study of the efficacy of cefuroxime axetil was conducted for the treatment of acute sinusitis in childhood. "
09/01/1998 - "were compared with those of cefuroxime axetil (CA) 250 mg b.i.d., each given for 10 days, in a nationwide, open, prospective, randomized trial of 1414 adults with acute sinusitis. "
02/01/1994 - "A review of all clinical data published to date demonstrates that cefuroxime axetil has been evaluated in the treatment of acute sinusitis and acute exacerbations of chronic sinusitis ("acute-on-chronic sinusitis") in 18 clinical trials involving 1516 assessable patients. "
09/01/2005 - "A 10-d course of cefuroxime axetil offered no clinical benefit to children with an acute respiratory illness and imaging evidence of acute sinusitis."
09/01/1996 - "It was found that cefuroxime axetil was efficaceous for the treatment of sinusitis in childhood."

03/01/1996 - "Cefuroxime axetil is an oral cephalosporin with proven efficacy in adult lower respiratory tract infections. "
01/01/1989 - "Cefuroxime-axetil is a safe and effective treatment of upper respiratory tract infections."
09/01/1985 - "Oral cefuroxime axetil is safe and effective in the therapy of lower respiratory tract infections."
07/01/1996 - "A number of studies have evaluated the efficacy of cefuroxime axetil as the oral component of intravenous to oral sequential therapy in hospitalised patients with lower respiratory tract infection. "
01/01/2001 - "In numerous randomised, controlled trials, 5 to 10 days' treatment with oral cefuroxime axetil (250 or 500 mg twice daily) was an effective treatment in patients with upper (URTI) and lower respiratory tract infections (LRTI) as assessed by clinical and bacteriological criteria. "

01/01/2000 - "Metaanalyses of clinical trials demonstrate that uncomplicated acute otitis media in children can be successfully treated with a 5-day course of cefuroxime axetil. "
08/01/1988 - "This study demonstrates the efficacy of cefuroxime axetil in the treatment of otitis media."
06/01/1998 - "This study indicates that cefuroxime axetil penetrates the inflamed middle ear effectively in acute otitis media after oral dosing. "
02/01/1996 - "Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media."
01/01/1995 - "The results indicate that the risk of treatment failure with cefuroxime axetil was increased in children with otitis media caused by S. "